Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis (Q53061157)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 22, 2010

Language	Label	Description	Also known as
English	Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis	scientific article published on October 22, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis (English)

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

author name string

Clarence De Belilovsky

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

Elia Roo-Rodriguez

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

Caroline Baudouin

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

Franck Menu

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

Bernard Chadoutaud

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

Philippe Msika

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20964572

7 August 2024

publication date

22 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

full work available at URL

https://www.tandfonline.com/doi/pdf/10.3109/09546634.2010.499932

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

Journal of Dermatological Treatment

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

22

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

359-365

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

Skin lipids and epidermal differentiation in atopic dermatitis

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

"Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis.

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

The benefits of sunflower oleodistillate (SOD) in pediatric dermatology

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement.

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

The Infants' Dermatitis Quality of Life Index

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

Peroxisome proliferator-activated receptors in cutaneous biology

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids

1 reference

https://api.crossref.org/works/10.3109/09546634.2010.499932

21 January 2018

The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaire

9

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

Effects of a low-potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis

10

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

Use of an Emollient As a Steroid‐Sparing Agent in the Treatment of Mild to Moderate Atopic Dermatitis in Children

11

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study

12

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients

14

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).

15

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model

17

1 reference

10.3109/09546634.2010.499932

https://api.crossref.org/works/10.3109/09546634.2010.499932

7 August 2024

Identifiers

10.3109/09546634.2010.499932

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20964572

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53061157&oldid=2222408278"